menu close
www.renasantbio.com

Renasant Bio Stock

Company Profile:

Renasant Bio pioneers oral small-molecule therapies aimed at reprogramming the underlying biology of inherited kidney disorders, notably autosomal dominant polycystic kidney disease. The company engineers corrective and potentiating drug candidates to restore protein function and slow disease progression, advancing a pipeline toward durable, disease-modifying treatments.

Sign up for SecondMarket® to view the market and buy or sell Renasant Bio Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Renasant Bio Funding

Sign up to gain insights into Renasant Bio funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Financing Round Date Amount Price per share* Valuation*
Series Seed Jul 10, 2025 26.67M
Price
Valuation
Series Seed Jul 15, 2024 27.83M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

Leverage Your Equity to Help Achieve More.

Renasant Bio Management Team

  • Board Member

    Anna French

  • Board Member

    Charlotte McKee

  • Board Member

    Deborah Palestrant

  • Board Member

    Evan Caplan

  • Board Member

    Kevin Bittermann

  • Board Member

    Natalie Holles

  • CEO

    Emily Conley

  • Chief Scientific Officer

    Gus Gustafson

Renasant Bio Major Investors

  • Qiming Venture Partners

  • 5AM Ventures

  • OrbiMed

Learn More About Renasant Bio Stock

Buy Renasant Bio Stock
01

Renasant Bio stock does not trade on public stock exchanges. Renasant Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Renasant Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Renasant Bio Stock
02

Renasant Bio Stock does not trade on public stock exchanges. In order to sell Renasant Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Renasant Bio Stock Price
03

Renasant Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Renasant Bio share price and other valuable private market data.

Read more about secondary market private company stock prices:

Renasant Bio Stock Ticker Symbol
04

There is no ticker symbol for Renasant Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Renasant Bio Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Renasant Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Renasant Bio Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Renasant Bio stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Renasant Bio Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Renasant Bio IPO
08

Renasant Bio is a private company and has not had an IPO. There is currently no Renasant Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Renasant Bio IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Renasant Bio Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Generate Biomedicines-Logo

Generate Biomedicines

Generative biology company with a revolutionary approach to drug development.

Pivot Bio-Logo

Pivot Bio

Developed a new in-field solution to biological nitrogen fixation for farmer, providing daily crop feeding without leaching, volatilization, or denitrification.

Source: Nasdaq Private Market Tape D®